Contact Us
Phase-Xs | Biologics & Biosimilars | Coherent Market Insights
  • Choose License Type

Global New Born Screening Market, by Product (Instruments, and Assay Kits and Reagents), by Test Type (Dry Blood Spot Test, Cardiac Test, Hearing Test, Urine Test, and Others), by Application (Phenylketonuria (PKU), Maple Syrup Urine Disease Critical Congenital Cardiac Disease, Hearing Disability, Sickle Cell Disease, and Others), by End User (Hospitals, Maternity and Specialty Clinics, and Diagnostic Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 1,412.2 Mn in 2021 and is expected to exhibit a CAGR of 10.5% during the forecast period (2021-2028), as highlighted in a new report published by Coherent Market Insights.

Increasing government support for new born screening and development in screening technology are expected to drive the market growth during the forecast period. For instance, New born Foundation in USA, a global non-profit organization is working in collaboration with public health and government agencies, healthcare providers and researchers, international NGOs working in the new born health ecosystem. Under New born Foundation, 3.2 million infants have been screened for heart defects and other health conditions. For instance, in 2013, New born Foundation launched BORN project, which impacted 31 provinces and around 400,000 new born, as well as 50 maternal and child health facilities in China.

Global New Born Screening Market– Impact of Coronavirus (COVID-19) Pandemic

The coronavirus or COVID-19 outbreak that started from Wuhan, China has spread across continents, affecting various industries globally. Supply of raw materials has been severely disrupted due to the forced quarantine, and lack of labour and raw materials. As the link between regional warehouses is not smooth, the transportation of raw materials between regions cannot be carried out successfully.

This shortage of raw materials and components have affected the supply chain of the global new born screening market. Supply chain and manufacturing activities in India, Italy, Spain, U.K., and the U.S. have been disrupted due to lockdowns implemented by governments in the past few months, while countries such as Saudi Arabia, UAE, Egypt, and others are facing problems with regards to transportation of instruments and kits used for new born screening.

Furthermore, the global new born screening market players are facing major challenges due to the COVID-19 pandemic on various fronts. The major challenges include supply of raw materials required for manufacturing instruments and reagent kits due to irregularities in transportation facility.

Browse Market Data 43 Tables and 40 Figures spread through 288 Pages and in-depth TOC on “Global New Born Screening Market”-  Forecast to 2028, Global New Born Screening Market, by Product (Instruments, and Assay Kits and Reagents), by Test Type (Dry Blood Spot Test, Cardiac Test, Hearing Test, Urine Test, and Others), by Application (Phenylketonuria, Critical Congenital Cardiac Disease, Maple Syrup Urine Disease, Hearing Disability, Sickle Cell Disease, and Others), by End User (Hospitals, Maternity and Specialty Clinics, and Diagnostic Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

https://www.coherentmarketinsights.com/market-insight/newborn-screening-market-2192

Moreover, high birth rate and increasing rate of neonatal diseases are expected to drive the market growth during the forecast period. Newborn population is one of the most vulnerable group population for various disease such as epilepsy, polio encephaliphitis, asthma, chronic obstructive pulmonary disease (COPD), and other respiratory disease, leukemia, diarrhea, anemia, and other rare disease that results in substantial economic burden. Hence, it is important to conduct new born screening for early detection of the diseases.

Key Takeaways of the Global New Born Screening Market:

  • The global new born screening market is expected to grow with a CAGR of 10.5% during the forecast period due to key players operating in the market are adopting strategies such as collaborations and acquisitions in order to expand their product portfolio. For instance, in November 2020, Natus Medical Inc., a medical device company acquired Babybe GmbH, a company that develops its patented remote mother to baby communication technology and soft robotics for neonatal healthcare. The company’s technology will add to Natus Medical Inc.’s Newborn Care portfolio of products.
  • Among product, instruments segment accounted for the highest CAGR in global new born screening market during forecast period. For instance, in July 2017, Department of Biotechnology (DBT), Ministry of Science and Technology, (Government of India) launched Sohum – the newborn hearing screening device developed by SIB startup, Sohum Innovation Labs India Pvt. Ltd., in India.
  • On the basis of test type, dry blood spot test accounted for the largest market share in the global new born screening market over the forecast period. For instance, in January 2019, Virginia Department of Health, announced the launch of Virginia New born Screening Program. The program include education about new born screening and conducting dried-blood spot screening tests, referral, follow-up and diagnosis, dietary and medical management, and treatment in Hospitals of Virginia.
  • On the basis of application, phenylketonuria (PKU) segment is expected to grow with the fastest growth rate in global new born screening market during forecast period. For instance, in 2017, Scientific Center of Obstetrics, Gynecology and Perinatology, Republican Medical Genetic Consultation, Almaty, Kazakhstan collaboratively initiated mass screening of Phenylketonuria (PKU) from year 2017 to 2019. They screened around 1 million newborns for Phenylketonuria (PKU) globally.
  • Among the end user, hospitals segment accounted for the largest share in global new born screening market in 2020. For instance, in May 2021, Cure Sanfilippo Foundation, a non –government organization (NGO) announced the initiation of the program called pilot new born screening for multiple disorders, which includes Sanfilippo syndrome type A and type B. This program is supported by eight New York hospitals such as the Maimonides Medical Center, in Brooklyn; New York-Presbyterian/Columbia University Medical Center, in Manhattan; Mount Sinai Hospital and Mount Sinai West, and the North Shore University Hospital, and others.
  • Among the regions, Asia Pacific region accounted for the largest CAGR in global new born screening market in 2021. Increasing programmes by key players for newborn screening expected to drive growth of the Asia Pacific newborn screening market during the forecast period.
  • Major players operating in global new born screening market include Agilent Technologies, Inc, Bio-rad laboratories, Inc. Medtronic Plc, Masimo Corporation, Natus Medical Inc., Perkin Elmer, Inc., ZenTec S.A., Trivitron Healthcare Pvt Ltd, Waters Technologies Corporation, Danaher Corporation, Baebies, Inc., Parseq Lab Co. Ltd, Chromesystem Instruments and Chemicals GmbH, and RECIPE Chemicals+ Instrument GmbH.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner

Subscribe Newsletter

Kindly Subscribe for our latest news & articles.